Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours

NCT02591030 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT02591030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02591030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase II/III Study, Assessing the Safety and Efficacy of Modified Folfirinox Versus Gemcis in Locally Advanced, Unresectable and/or Metastatic Bile Duct Tumours
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Phase 2/3
Overall status
Completed
Start date
December 15, 2015
Completion date
January 16, 2020
Enrollment
191 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer